Mylan Pharmaceuticals Inc recalls Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled…
Labeling: Missing Label: label missing from some Semglee prefilled pens.
Read the official notice →- Date
- 2022-01-26
- Country
- United States
- Brand
- Mylan Pharmaceuticals
- Product
- Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens…
- Classification
- Class I
- Units
- Nationwide in the USA and Thailand.
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Mylan Pharmaceuticals recalls
- 2025-03-26
USMYLAN PHARMACEUTICALS INC recalls Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC…
Failed Dissolution Specifications - low dissolution results
- 2022-08-03
- US
Mylan Pharmaceuticals Inc recalls Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons…
Labeling: Missing label: Label missing from some prefilled pens.
FDA · DrugMylan Pharmaceuticals IncProduct was distributed nationwide within the United StatesOfficial notice → - 2022-05-04
- US
- 2022-04-27
- US
Mylan Pharmaceuticals Inc recalls Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505…
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
- 2022-04-13
- US
Mylan Pharmaceuticals Inc recalls Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV…
Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine…
- 2022-02-02
- US
Mylan Pharmaceuticals Inc recalls Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only,…
cGMP deficiencies
FDA · DrugMylan Pharmaceuticals IncRecalled product was distributed nationwide within the United States.Official notice →
Other drugs & medical recalls in the United States
- 2022-01-26
- US
Luminex Corporation recalls ARIES HSV 1&2 Assay, Part Number/REF 50-10017
Impacted lot may leak inside the ARIES instrument.
FDA · DeviceLuminex CorporationWorldwide distribution - US Nationwide distribution in the states of Alabama,…Official notice → - US
Stanley Security Solutions Inc recalls Senior Living Arial Emergency and Nurse Call Systems
Systems are not alarming due to increased memory consumption.
FDA · DeviceStanley Security Solutions IncWorldwide distribution - US Nationwide distribution in the states of FL, MD,…Official notice → - US
ev3 Inc. recalls Medtronic HawkOne Directional Atherectomy System, Catalog numbers H1-M and H1-M-INT., Multi-vessel, 6F (2.2 mm) Recommended sheath, 0.014"…
Reports have been received of tip damage during use of the devices which resulted in some instances of tip detachment and embolization.
FDA · Deviceev3 Inc.Worldwide Distribution: US (nationwide), including PR; and Foreign…Official notice → - US
Medique Products recalls Physicians CARE Extra Strength PAIN RELIEVER [Acetaminophen, Aspirin (NSAID), and Caffeine], 250 mg, 250 mg, 65 mg, packaged as 100-count…
CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.
- US
- US
Mayne Pharma Inc recalls Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC…
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.